Trials / Withdrawn
WithdrawnNCT02226133
Video-Assisted Left Atrial Appendage Exclusion Trial
A Clinical Trial to Evaluate Safety and Effectiveness of the LAAx,Inc., TigerPaw System II LAA Exclusion Device for the Exclusion of the Left Atrial Appendage Via Video-Assisted Thoracoscopic Surgery ("VATS")
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- LAAx, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Exclusion of the LAA(Left Atrial Appendage) using the TigerPaw II System with VATS technique is safe and effective.
Detailed description
The objective of this confirmatory study is to demonstrate that the LAAx, Inc. TigerPaw® II System can be safely and effectively used to exclude the Left Atrial Appendage (LAA) during cardiac surgery utilizing thoracoscopic camera and light source and thus remove, from the cleared indication for use, the direct vision limitation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LAAx, Inc. TigerPaw® System II | Exclusion of Left Atrial Appendage. |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2015-09-01
- Completion
- 2015-12-01
- First posted
- 2014-08-27
- Last updated
- 2015-05-05
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02226133. Inclusion in this directory is not an endorsement.